IL52617A - Atoxic,immunogenic product of tetanus toxin - Google Patents
Atoxic,immunogenic product of tetanus toxinInfo
- Publication number
- IL52617A IL52617A IL52617A IL5261777A IL52617A IL 52617 A IL52617 A IL 52617A IL 52617 A IL52617 A IL 52617A IL 5261777 A IL5261777 A IL 5261777A IL 52617 A IL52617 A IL 52617A
- Authority
- IL
- Israel
- Prior art keywords
- atoxic
- tetanus toxin
- immunogenic product
- immunogenic
- product
- Prior art date
Links
- 108010055044 Tetanus Toxin Proteins 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 229940118376 tetanus toxin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2634584A DE2634584C3 (de) | 1976-07-31 | 1976-07-31 | Atoxisches, immunogenes Produkt aus Tetanus-Toxin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL52617A0 IL52617A0 (en) | 1977-10-31 |
| IL52617A true IL52617A (en) | 1980-12-31 |
Family
ID=5984461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL52617A IL52617A (en) | 1976-07-31 | 1977-07-29 | Atoxic,immunogenic product of tetanus toxin |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5326319A (de) |
| AT (1) | AT362498B (de) |
| AU (1) | AU516191B2 (de) |
| BE (1) | BE857373A (de) |
| CA (1) | CA1099635A (de) |
| DE (1) | DE2634584C3 (de) |
| DK (1) | DK342577A (de) |
| EG (1) | EG12732A (de) |
| FI (1) | FI58500C (de) |
| FR (1) | FR2360315A1 (de) |
| GB (1) | GB1570958A (de) |
| IE (1) | IE45539B1 (de) |
| IL (1) | IL52617A (de) |
| IT (1) | IT1085660B (de) |
| LU (1) | LU77874A1 (de) |
| NL (1) | NL7708279A (de) |
| NO (1) | NO772704L (de) |
| SE (1) | SE7708693L (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200627A (en) | 1976-07-31 | 1980-04-29 | Behringwerke Aktiengesellschaft | Atoxic, immunogenic product of tetanus toxin |
| GB8516442D0 (en) * | 1985-06-28 | 1985-07-31 | Wellcome Found | Cloned antigen |
-
1976
- 1976-07-31 DE DE2634584A patent/DE2634584C3/de not_active Expired
-
1977
- 1977-07-26 NL NL7708279A patent/NL7708279A/xx not_active Application Discontinuation
- 1977-07-27 EG EG446/77A patent/EG12732A/xx active
- 1977-07-27 AU AU27380/77A patent/AU516191B2/en not_active Expired
- 1977-07-28 FI FI772305A patent/FI58500C/fi not_active IP Right Cessation
- 1977-07-28 SE SE7708693A patent/SE7708693L/ not_active Application Discontinuation
- 1977-07-29 AT AT563477A patent/AT362498B/de not_active IP Right Cessation
- 1977-07-29 IL IL52617A patent/IL52617A/xx unknown
- 1977-07-29 CA CA283,802A patent/CA1099635A/en not_active Expired
- 1977-07-29 JP JP9213677A patent/JPS5326319A/ja active Pending
- 1977-07-29 IE IE1590/77A patent/IE45539B1/en unknown
- 1977-07-29 NO NO772704A patent/NO772704L/no unknown
- 1977-07-29 LU LU77874A patent/LU77874A1/xx unknown
- 1977-07-29 DK DK342577A patent/DK342577A/da not_active Application Discontinuation
- 1977-07-29 GB GB31968/77A patent/GB1570958A/en not_active Expired
- 1977-07-29 IT IT26354/77A patent/IT1085660B/it active
- 1977-08-01 BE BE179821A patent/BE857373A/xx unknown
- 1977-08-01 FR FR7723600A patent/FR2360315A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| LU77874A1 (de) | 1978-02-02 |
| FI772305A7 (de) | 1978-02-01 |
| NL7708279A (nl) | 1978-02-02 |
| GB1570958A (en) | 1980-07-09 |
| DE2634584A1 (de) | 1978-02-02 |
| NO772704L (no) | 1978-02-01 |
| AT362498B (de) | 1981-05-25 |
| FR2360315A1 (fr) | 1978-03-03 |
| IT1085660B (it) | 1985-05-28 |
| EG12732A (en) | 1979-09-30 |
| AU516191B2 (en) | 1981-05-21 |
| ATA563477A (de) | 1980-10-15 |
| IE45539B1 (en) | 1982-09-22 |
| DK342577A (da) | 1978-02-01 |
| SE7708693L (sv) | 1978-02-01 |
| BE857373A (fr) | 1978-02-01 |
| IE45539L (en) | 1978-01-31 |
| CA1099635A (en) | 1981-04-21 |
| AU2738077A (en) | 1979-02-01 |
| JPS5326319A (en) | 1978-03-11 |
| FI58500C (fi) | 1981-02-10 |
| FI58500B (fi) | 1980-10-31 |
| FR2360315B1 (de) | 1980-04-11 |
| IL52617A0 (en) | 1977-10-31 |
| DE2634584C3 (de) | 1979-11-08 |
| DE2634584B2 (de) | 1979-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ181619A (en) | 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines | |
| JPS52151794A (en) | Production of insulin by bacterium converted character thereof hereditary | |
| IL45960A (en) | Atoxic, immunogenic product from tetanus toxin | |
| SU762760A3 (en) | Method of preparing 2,2,6-trimethyl-1-cyclohexene-2-vinylalkanoates | |
| AU504575B2 (en) | Tetanus toxin derivatives | |
| GB1520958A (en) | 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins | |
| CY1128A (en) | 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carbocylic acid-1,dioxide and a process for its preparation | |
| PT66743A (en) | Process for preparing novel 2-oxy-5-isopropylidene-7-hydroxy-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocins | |
| NZ185962A (en) | Stabilisation of 1,1,1-tricholorethane | |
| GB1532697A (en) | 2,3-dihydroergolines | |
| SU725557A3 (en) | Method of preparing 1,2,3-thiadiazol-5-yl-ureas | |
| AU516191B2 (en) | Atoxic, immunogenic product of tetanus toxin | |
| PH14168A (en) | 2,4-pyrrolidinediones | |
| GB1557694A (en) | 2,9 dichlorquinacridone | |
| GB1532038A (en) | Process for the preparation of 2,3,5-trichloropyridine | |
| JPS5328700A (en) | Waterrsoluble crossslinked nitrogenncontaining condensate product | |
| ZA764087B (en) | Continuous production of 2,5-dioxo-1-oxa-2-phospholanes | |
| GB1483330A (en) | 2,5-dimethoxy-4-chloroaniline | |
| NZ182127A (en) | 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones | |
| JPS5283928A (en) | Tetanus toxin derivative | |
| ZA764890B (en) | Production of n,m-diethyl 2 (alpha-naphthoxy) propionamid | |
| JPS527954A (en) | Novel thienyll prostaglandine and production thereof | |
| ZA774205B (en) | Method of preparing 2,3-dichloroanisole | |
| GR58594B (en) | Preparation method of 2-halogenmethyl-1,4,-benzodiazepine | |
| AU1483576A (en) | 16,16-dimethyl-prostaglandins |